Children and Adolescents with Early Treated Phenylketonuria: Cognitive Development and Fluctuations of Blood Phenylalanine Levels
International Journal of Environmental Research and Public Health · 2024
DOI: 10.3390/ijerph21040431 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Environmental Research and Public Health, 2024. Verfasst von Reinhold Feldmann und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Pediatrics, Münster University Children's Hospital, 48149 Münster, Germany. Hauptthemen laut MEDLINE: Phenylketonurias, Phenylalanine, Cognition, Biopterins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BioMarin Pharmaceutical Inc..
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
We assessed the relationship between the cognitive development of children and adolescents with phenylketonuria (PKU) and fluctuations in peripheral phenylalanine (Phe) levels.
Methods
We examined the neurocognitive performance of 33 children and adolescents with early treated PKU, of whom 18 were treated with sapropterin dihydrochloride, and 15 were on a classic diet. For 26 weeks, patients were assessed weekly for their blood phenylalanine (Phe) levels. Phe levels were analyzed for fluctuations indicated by the individual standard deviation. Fluctuations were compared to the standard deviation of 26 Phe level measurements before the study interval. We also assessed the concurrent IQ of the patients. This was repeated at one-, two-, and seven-year intervals.
Results
Full-scale IQ in patients treated with a classic diet did not change within the follow-up. In patients treated with Sapropterin dihydrochloride, however, there was a considerable gain in full-scale IQ. This was particularly true if blood Phe fluctuations increased in patients of this treatment group.
Conclusions
Sapropterin dihydrochloride enhances Phe tolerance in patients with PKU. Increasing blood Phe fluctuations following enhanced Phe tolerance may indicate that the treatment not only allows patients to relax their Phe-restricted diet but also may support cognitive development in patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Pediatrics, Münster University Children's Hospital, 48149 Münster, Germany.
- Children's Healthcare Center "Haus Walstedde", 48317 Drensteinfurt, Germany.
ORCID-Profile: Frank Rutsch
Förderung
- BioMarin Pharmaceutical Inc.
Zitieren
APA
Feldmann, R., Och, U., Beckmann, L. S., Weglage, J., & Rutsch, F. (2024). Children and Adolescents with Early Treated Phenylketonuria: Cognitive Development and Fluctuations of Blood Phenylalanine Levels. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph21040431
Vancouver
Feldmann R, Och U, Beckmann LS, Weglage J, Rutsch F. Children and Adolescents with Early Treated Phenylketonuria: Cognitive Development and Fluctuations of Blood Phenylalanine Levels. International Journal of Environmental Research and Public Health. 2024. doi:10.3390/ijerph21040431
BibTeX
@article{Feldmann2024,
author = {Feldmann, Reinhold and Och, Ulrike and Beckmann, Lisa Sophie and Weglage, Josef and Rutsch, Frank},
title = {Children and Adolescents with Early Treated Phenylketonuria: Cognitive Development and Fluctuations of Blood Phenylalanine Levels},
journal = {International Journal of Environmental Research and Public Health},
year = {2024},
doi = {10.3390/ijerph21040431}
}
EUVIMED